Tardive and idiopathic oromandibular dystonia: A clinical comparison

Journal of Neurology Neurosurgery and Psychiatry

Volumn 68, Issue 2, 2000, Pages 186-190

  Tan, Eng King ^a   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Comparison; Idiopathic; Oromandibular dystonia; Tardive

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; CHLORPROMAZINE; HALOPERIDOL; METOCLOPRAMIDE; NEUROLEPTIC AGENT; PERPHENAZINE; PHENTERMINE; PIMOZIDE; PROCHLORPERAZINE; THIORIDAZINE; TIOTIXENE; TRAZODONE; TRIFLUOPERAZINE;

ADOLESCENT; ADULT; AFFECTIVE NEUROSIS; AGED; AKATHISIA; ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; DEMOGRAPHY; DISEASE DURATION; DRUG EFFICACY; DRUG RESPONSE; DYSTONIA; FACE MUSCLE; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; IDIOPATHIC DISEASE; JAW DISEASE; LIMB DISEASE; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MOUTH DISEASE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SCHIZOPHRENIA; SPINAL CORD DISEASE; STEREOTYPY; TONGUE DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; DISEASE PROGRESSION; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; MALE; MANDIBLE; MIDDLE AGED; MOVEMENT DISORDERS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0034056858     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.68.2.186     Document Type: Article

References (40)

1. Jankovic J. Tardive syndromes and other drug-induced movement disorders. Clin Neuropharmacol 1995;3:197-214.
2. Burke RE, Fahn S, Jankovic J, et al. Tardive dystonia: late onset and persistent dystonia caused by antipsychotic drugs. Neurology 1982;32:1335-46.
3. Kang UJ, Burke RE, Fahn S. Natural history and treatment of tardive dystonia. Mov Disord 1986;3:193-208.
4. Burke RE, Kang UJ. Tardive dystonia: clinical aspects and treatment. In: Jankovic J, Tolosa E, eds. Advances in neurology. Facial dyskinesias. New York, Raven, 1988;49:199-210.
5. Wojcik JD, Falk WE, Fink JS, et al. A review of 32 cases of tardive dystonia. Am J Psychiatry 1991;148:1055-9.
6. Friedman JH, Kucharski LT, Wagner RL. Tardive dystonia in a psychiatric hospital. J Neurol Neurosurg Psychiatry 1987;50:801-3.
7. Kiriakakis V, Bhatia KP, Quinn NP, et al. The natural history of tardive dystonia: a long-term follow up study of 107 cases. Brain 1998;121:2053-66.
8. Stacy M, Cardoso F, Jankovic J. Tardive stereotypy and other movement disorders in tardive dyskinesias. Neurology 1993;43:937-41.
9. Jankovic J. Stereotypies. In: Marsden CD, Fahn S, eds. Movement disorders 3. London: Butterworth Heinemann, 1994:503-17.
10. van Harten PN, Hoek HW, Matroos GE, et al. The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curacao extrapyramidal syndromes study II. Schizophr Res 1997:235-42.
11. Cardoso F, Jankovic J. Oromandibular dystonia. In: Tsui JK, Calne DB, eds. Handbook of dystonia. New York: Marcel Dekker, 1995:181-90.
12. Jankovic J. Etiology and differential diagnosis of blepharospasm and oromandibular dystonia. In: Jankovic J, Tolosa E, eds. Advances in neurology. Facial dyskinesias. New York, Raven, 1988;49:103-116.
13. Tolosa E, Marti MJ. Blepharospasm-oromandibular dystonia (Meige's syndrome): clinical aspects. In: Jankovic J, Tolosa E, eds. Adv Neurol, vol 49. Facial dyskinesias. New York: Raven, 1988;49:73-84.
14. Defazio G, Lamberti P, Lepore V, et al. Facial dystonia: clinical features, prognosis and pharmacology in 31 patients. Ital J Neurol Sci 1989;10:553-60.
15. Nutt JG, Muenter MD, Aronson A, et al. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord 1988;3:188-94.
16. Jankovic J, Fahn S. Dystonic disorders. In: Jankovic J, Tolosa E, eds. Parkinson's disease and movement disorders. 3rd ed. Baltimore: Williams and Wilkins, 1998:513-51.
17. Jankovic J. Cranial-cervical dyskinesia. In: Appel S, ed. Current neurology. Vol 6. Chicago: Year Book Medical, 1986:153-76.
18. Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry 1990;53:633-9.
19. Tan EK, Jankovic J. Botulinum toxin A in patients with oromandibular dystonia: long term follow up. Neurology 1999 (in press).
20. Miller LG, Jankovic J. Drug-induced dyskinesias: an overview. In: Joseph AB, Young RR, eds. Movement disorders in neurology and psychiatry, 2nd ed. Mailden, MA: Blackwell Science, 1999;2:5-30.
21. Casey DE. Tardive dyskinesia and atypical antipsychotic drugs. Schizophr Res 1999;35(suppl):S61-6.
22. Jeste DV, Lacro JP, Palmer B, et al. Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients. Am J Psychiatry 1999;156: 309-11.
23. Jankovic J. Cranial-cervical dyskinesias: an overview. In: Jankovic J, Tolosa E, eds. Advances in neurology. Facial dyskinesias. New York: Raven Press, 1988;49:1-13.
24. Greene P, Shale H, Fahn S. Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs. Mov Disord 1988;3:46-60.
25. Klawans HL, Tanner CM. Cholinergic pharmacology of blepharospasm with oromandibular dystonia (Meige's syndrome). In: Jankovic J, Tolosa E, eds. Advances in neurology. Facial dyskinesias. New York: Raven, 1988;49:443-9.
26. Jankovic J, Beach J. Long term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 1997;48:358-62.
27. Brin MF, Blitzer A, Herman S, et al. Oromandibular dystonia: treatment of 96 patients with botulinum toxin A. In: Jankovic J, Hallett M eds: Therapy with botulinum toxin. New York: Marcel Dekker, 1994:429-35.
28. Tarsy D, Kaufman D, Sethi KD, et al. An open label study of botulinum toxin A for treatment of tardive dystonia. Clin Neuropharmacol 1997;20:90-3.
29. Sankhla C, Lai EC, Jankovic J. Peripherally induced oromandibular dystonia. J Neurol Neurosurg Psychiatry 1998;65:722-8.
30. Molho ES, Feustel PJ, Factor SA. Clinical comparison of tardive and idiopathic cervical dystonia. Mov Disord 1998; 3:486-9.
31. Kunig G, Pogarell O, Oertel WH. Comparison of idiopathic and tardive cervical dystonia: clinical and polymyographic observations [abstract]. Mov Disord 1996;11(suppl 1):223.
32. Meige H. Les convulsions de la face: une forme clinique de convulsions faciales, bilaterale et mediane. Rev Neurol (Paris) 1910;21:437-43.
33. Hardie RJ, Lees AJ. Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa. J Neurol Neurosurg Psychiatry 1988;51:850-4.
34. Jankovic J, Casabona J. Coexistence of tardive dyskinesia and parkinsonism. Clin Neuropharmacol 1987;10:511-21.
35. Campbell M, Locascio JJ, Choroco MC, et al. Stereotypies and tardive dyskinesia: abnormal movements in autistic children. Psychopharmacol Bull 1990;26:260-6.
36. Dura JR, Mullick JA, Rasnake LK. Prevalence of stereotypy among institutionalized, nonambulatory, profoundly men-tally retarded people. American Journal of Mental Deficiency 1987;91:548-9.
37. Andreassen OA, Finsen B, Ostergaard K, et al. The relationship between oral dyskinesias produced by long-term haloperidol treatment, the density of striatal pre-proenkephalin messenger RNA and enkephalin peptide, and the number of striatal neurons expressing pre-proenkephalin messenger RNA in rats. Neuroscience 1999; 88:27-35.
38. Yassa R, Nair V, Iskandar H. A comparison of severe tardive dystonia and severe tardive dyskinesia. Acta Psychiatr Scand 1989;80:155-9.
39. Shapleske J, Mickay AP, Mckenna PJ. Successful treatment of tardive dystonia with clozapine and clonazepam. Br J Psychiatry 1996;168:516-18.
40. Wootton-Watts M, Tan EK, Jankovic J. Bruxism and cranial-cervical dystonia: is there a relationship? Cranio 1999;17:1-6.